跳至主要内容
临床试验/IRCT20220723055527N1
IRCT20220723055527N1已完成1 期

A clinical trial to compare the effectiveness of the total neoadjuvant therapy with standard approach in rectal adenocarcinoma patients

Mashhad University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Patients with rectal adenocarcinoma based on pathological diagnosis
  • The zero to two level of Eastern Cooperative Oncology Group (ECOG)
  • Healthy functioning bone marrow
  • Healthy functioning liver
  • Healthy functioning kidneys

排除标准

  • Having simultaneous adenocarcinoma in other areas of the colon
  • Having metastasis
  • History of previous malignancy
  • History of chemotherapy
  • History of pelvic radiotherapy
  • Having inflammatory intestinal disease
  • Having bilateral hip prosthesis
  • Having allergic to 5-fluorouracil and its other derivatives
  • Having allergic to oxaliplatin

研究者

相似试验